Raju Mohan is a co-founder of Ralexar Therapeutics and has served as EVP of Research since January 2014. Raju was the founder and President of Anayaderm, a specialty dermatology company he founded in 2011 and acquired by Alexar in 2014. From 2001 to 2004, Raju was the Vice President of Chemistry at X-Ceptor (acquired by Exelixis) and Vice-President and site-head for Exelixis’ San Diego site from 2006 to 2010. From 1997 to 2000, Raju held increasingly senior positions at Berlex Biosciences, a subsidiary of Bayer/Schering AG. Raju is responsible for the discovery of multiple small-molecule compounds that have entered the clinic including one currently in Phase 3 trials. Raju has published extensively in peer-reviewed journals and is an inventor on 50 issued US patents. Raju received his Ph.D. in Chemistry from the University of Illinois at Urbana-Champaign and his Master’s degree from the Indian Institute of Technology.